- Home
- ABUS vs OST Comparison
ABUS vs OST Comparison
Compare ABUS & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- OST
- Stock Information
- Founded
- ABUS 2005
- OST 2010
- Country
- ABUS United States
- OST China
- Employees
- ABUS N/A
- OST N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- OST Industrial Machinery/Components
- Sector
- ABUS Health Care
- OST Technology
- Exchange
- ABUS Nasdaq
- OST Nasdaq
- Market Cap
- ABUS 670.3M
- OST 601.6M
- IPO Year
- ABUS N/A
- OST 2022
- Fundamental
- Price
- ABUS $3.43
- OST $7.68
- Analyst Decision
- ABUS Strong Buy
- OST
- Analyst Count
- ABUS 4
- OST 0
- Target Price
- ABUS $5.50
- OST N/A
- AVG Volume (30 Days)
- ABUS 610.0K
- OST 6.9M
- Earning Date
- ABUS 07-31-2025
- OST 01-27-2025
- Dividend Yield
- ABUS N/A
- OST N/A
- EPS Growth
- ABUS N/A
- OST N/A
- EPS
- ABUS N/A
- OST N/A
- Revenue
- ABUS $6,403,000.00
- OST $32,463,213.00
- Revenue This Year
- ABUS $3.35
- OST N/A
- Revenue Next Year
- ABUS N/A
- OST N/A
- P/E Ratio
- ABUS N/A
- OST N/A
- Revenue Growth
- ABUS N/A
- OST N/A
- 52 Week Low
- ABUS $2.71
- OST $0.78
- 52 Week High
- ABUS $4.73
- OST $7.75
- Technical
- Relative Strength Index (RSI)
- ABUS 50.84
- OST 83.37
- Support Level
- ABUS $3.46
- OST $6.07
- Resistance Level
- ABUS $3.65
- OST $6.91
- Average True Range (ATR)
- ABUS 0.12
- OST 0.44
- MACD
- ABUS -0.00
- OST 0.06
- Stochastic Oscillator
- ABUS 35.29
- OST 96.93
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.